Channel Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
1.070
-0.010 (-0.93%)
May 13, 2025, 4:00 PM - Market closed

Channel Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
74----
Enterprise Value
85----
Last Close Price
1.070.64----
PB Ratio
-2.41-1.42----
Debt / Equity Ratio
-0.60-0.80-0.20-0.15-0.30-0.07
Quick Ratio
0.030.130.020.02--
Current Ratio
0.180.340.020.02-0.02
Return on Assets (ROA)
-188.95%-645.79%-5663.30%---
Earnings Yield
-121.81%-205.89%----
Buyback Yield / Dilution
-336.69%-336.69%-193.25%---
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q